Development asset linked to Second Affiliated Hospital in public FDA and regional records.
pharma · Multiple System Atrophy · Asthma
Second Affiliated Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Second Affiliated Hospital drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Hangzhou, CN HQ
1869 Founded
16 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Hangzhou, CN
- Founded
- 1869
- Employees
- 16
- Programs
- 2
- Drugs
- 4
- Patents
- 0
Second Affiliated Hospital pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Second Affiliated Hospital drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Second Affiliated Hospital in public FDA and regional records.
-
Development asset linked to Second Affiliated Hospital in public FDA and regional records. Mechanism: Cysteinyl leukotriene receptor 1 antagonist.
- Mechanism
- Cysteinyl leukotriene receptor 1 antagonist
-
Development asset linked to Second Affiliated Hospital in public FDA and regional records.